Manufacturing, Cell Therapies

NIH and Bill & Melinda Gates Foundation to Invest $200 Million into Sickle Cell Disease and HIV Gene-Based Cures

October 24, 2019

The goal of the investment is for the cures to be made available across the globe, including in sub-Saharan Africa’s low-resource communities.

Takeda Acquires Global License for Celiac Disease Therapy for $420 million

October 24, 2019

The therapy received positive results in a randomized, double-blind, placebo-controlled clinical trial in 34 adults with proven celiac disease.

Aldveron and Nature Technology Corporation Collaborate to Offer Gene Therapy Services

October 24, 2019

Under the agreement, gene and cell therapy companies can go directly to Aldevron for NTC’s technology without acquiring a license from NTC.

BioInvent Enters into Production Agreement Expected to Generate $30 million

October 24, 2019

The company will produce the anti-HER3 antibody drug HMBD-001for use within a clinical partnership between Cancer Research UK and Hummingbird Bioscience to test the agent in a Phase I trial.

CombiGene and Cobra Biologics Sign Agreement for Epilepsy Gene Therapy Drug

October 16, 2019

The long-term agreement gives CombiGene the authority to manufacture and commercialize the drug if it is approved after clinical studies.

MilliporeSigma Acquires FloDesign Sonics for Acoustic Technology for Cell Therapy

October 10, 2019

MilliporeSigma will now be the first company to make acoustic technology available for cell therapy manufacturing.

Lonza Enters Manufacturing Agreement with Cellectis for CAR T Cell Development

October 03, 2019

Manufacturing of the cell line will take place at Lonza’s GMP facility in Geleen, Netherlands.

Astellas Invests $13 Million into Innovation Facilities for Cell and Gene Therapy

October 02, 2019

The new incubators are set to be operational starting in 2021.

NIH Announces New Viral Vector for Sickle Cell Disease

October 02, 2019

Researchers used advanced animal model lab tests to determine the new vector is 10 times more efficient at incorporating corrective genes into bone marrow stem cells than traditional vectors.

Tracking Raw Materials in Biopharma Manufacturing

October 02, 2019

Automated, electronic systems for raw materials tracking improve efficiency and prevent mistakes in biopharma manufacturing.